Medical Device and Pharmaceutical Industries Can Leverage New GS1 US Guideline for Sharing Vital Data prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
email article
WASHINGTON President Biden will sign an executive order Wednesday afternoon directing federal agencies to study ways to secure the supply chain for pharmaceutical products and other manufactured goods, White House officials said Tuesday evening. Last year in the early months of the pandemic, we saw shortages of masks, gloves, and other critical personal protective equipment (PPE), a senior administration official told reporters in a background briefing. President Biden committed last year to directing the U.S. to take a comprehensive approach to securing supply chains, and the executive order the president will sign tomorrow afternoon kicks off that process.
A group of health care organizations have written a letter to Jeff Zients, Acting Director of the Office of Management and Budget (OMB), asking for the release of FDA s proposed rule on Unique Device Identifiers (UDIs). According to FDA, Section 226 of the Food and Drug Administration Amendments Act of 2007 (FDAAA) directs FDA to issue regulations establishing a UDI system for medical devices. This system is intended to improve the identification of devices throughout distribution and use.
The associations that submitted the letter are:
• Association of Healthcare Resource and Materials Management (AHRMM) - www.ahrmm.org
• Healthcare Supply Chain Association (HSCA) - www.supplychainassociation.org